The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA1538801
Max Phase: Preclinical
Molecular Formula: C16H13N3O
Molecular Weight: 263.30
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: C/C(=C\c1ccccc1)C(=O)n1nnc2ccccc21
Standard InChI: InChI=1S/C16H13N3O/c1-12(11-13-7-3-2-4-8-13)16(20)19-15-10-6-5-9-14(15)17-18-19/h2-11H,1H3/b12-11+
Standard InChI Key: HHJAWIYTXXKCQC-VAWYXSNFSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 263.30Molecular Weight (Monoisotopic): 263.1059AlogP: 3.18#Rotatable Bonds: 2Polar Surface Area: 47.78Molecular Species: NEUTRALHBA: 4HBD: 0#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0CX Acidic pKa: CX Basic pKa: CX LogP: 3.38CX LogD: 3.38Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.67Np Likeness Score: -1.13
References 1. PubChem BioAssay data set, 2. Tan X, Furio L, Reboud-Ravaux M, Villoutreix BO, Hovnanian A, El Amri C.. (2013) 1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases., 23 (16): [PMID:23849879 ] [10.1016/j.bmcl.2013.06.039 ]